Drugs that alter the hemostatic mechanism.
This article offers a brief review of antiplatelet drugs, anticoagulants, fibrinolysins, and antifibrinolysins. Aspirin and heparin are discussed in detail. Warfarin, streptokinase, urokinase, and tissue-type plasminogen activator are also considered. Indications for use, mechanism of action, monitoring therapy, and current investigational studies are discussed.
Rackear
D G
DG
University of California School of Veterinary Medicine, Davis.
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006487:Hemostasis / Q000187:drug effects*; D006493:Heparin / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D001241:Aspirin